✦ LIBER ✦

Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet

✍ Scribed by Geoffrey W. Hanks; Magdi Hanna; Ilora Finlay; David John Radstone; Tom Keeble

Book ID: 113382173
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 474 KB
Volume: 10
Category: Article
ISSN: 0885-3924
DOI: 10.1016/0885-3924(94)00067-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled-release morphine sulfate: ana

Controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet

✍ R.K. Portenoy; M. Maldonado; R. Fitzmartin; R. Kaiko; R. Kanner 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Oral controlled-release morphine sulfate

Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients

✍ Russell K. Portenoy; Mathelyn Maldonado; Ronald Fitzmartin; Robert F. Kaiko; Ron 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Pharmacokinetics and clinical efficacy o

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

✍ Michael P. Thirlwell; Paul A. Sloan; Jean A. Maroun; Gerry J. Boos; Jean-Guy Bes 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

Pharmacokinetic profile of a new control

Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab®)

✍ Armel Stockis; Steven De Bruyn; Xavier Deroubaix; Bernard Jeanbaptiste; Edouard 📂 Article 📅 2002 🏛 Elsevier Science 🌐 French ⚖ 131 KB

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of Naprosyn CR 500 mg tablet, a new controlled-release formulation of naproxen, after single and multiple dosing

✍ Sompon Wanwimolruk; Stanley Lipschitz; Michael S. Roberts 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Comparison of a 10-mg controlled release

Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients

✍ Carl Gustaf Nilsson; Eeva Lukkari; Mervi Haarala; Aarre Kivelä; Tiina Hakonen; P 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Oxybutynin has long been used for the treatment of patients with detrusor overactivity and urinary urge incontinence. The short half-life of oxybutynin administered as a conventional tablet formulation or syrup requires 2-3 times daily dosage to be effective. A new controlled release (CR) tablet for